Alberto Lazarowski Selected Research

3-Mercaptopropionic Acid (3 Mercaptopropionic Acid)

3/2009	Differential hippocampal pharmacokinetics of phenobarbital and carbamazepine in repetitive seizures induced by 3-mercaptopropionic acid.
2/2007	Nimodipine restores the altered hippocampal phenytoin pharmacokinetics in a refractory epileptic model.
2/2004	Neuronal and glial expression of the multidrug resistance gene product in an experimental epilepsy model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alberto Lazarowski Research Topics

Disease

14	Drug Resistant Epilepsy 01/2022 - 02/2004
12	Seizures (Absence Seizure) 01/2022 - 02/2004
11	Epilepsy (Aura) 01/2021 - 02/2004
10	Hypoxia (Hypoxemia) 01/2021 - 07/2007
5	Inflammation (Inflammations) 01/2021 - 05/2009
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 02/2018
4	Neoplasms (Cancer) 04/2019 - 02/2004
4	Brain Hypoxia (Cerebral Hypoxia) 01/2019 - 01/2011
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2007
3	Sudden Unexpected Death in Epilepsy 01/2021 - 12/2018
2	Infections 01/2021 - 01/2018
2	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 06/2020 - 02/2014
2	Alzheimer Disease (Alzheimer's Disease) 06/2015 - 07/2013
2	Brain Injuries (Brain Injury) 01/2011 - 05/2009
2	Ischemia 01/2011 - 05/2009
2	Stroke (Strokes) 01/2011 - 05/2009
2	Tuberous Sclerosis (Bourneville's Disease) 02/2004 - 02/2004
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Iron Overload 01/2021
1	Hemochromatosis (Bronze Diabetes) 01/2021
1	Cardiac Arrhythmias (Arrythmia) 01/2021
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2021
1	Neuroinflammatory Diseases 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2020
1	Sudden Death 02/2018
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2018
1	Encephalitis (Encephalitis, Rasmussen) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2015
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2015
1	Multiple Myeloma 06/2015
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2015
1	Melanoma (Melanoma, Malignant) 06/2015
1	Mastocytosis 06/2015
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 06/2015
1	Dyskinesias (Dyskinesia) 08/2014
1	Parkinson Disease (Parkinson's Disease) 08/2014
1	Hemolysis 02/2014
1	Brain Neoplasms (Brain Tumor) 01/2014
1	Malformations of Cortical Development 01/2014

Drug/Important Bio-Agent (IBA)

16	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022 - 02/2004
9	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 02/2004
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2004
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2007
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 05/2009
4	ATP-Binding Cassette Transporters (ABC Transporters)IBA 01/2021 - 01/2007
3	Multidrug Resistance-Associated ProteinsIBA 01/2022 - 01/2007
3	CannabidiolIBA 03/2021 - 01/2020
3	Pentylenetetrazole (Metrazol)IBA 01/2021 - 01/2013
3	Pilocarpine (Ocusert)FDA LinkGeneric 01/2021 - 02/2018
3	Neuroprotective AgentsIBA 01/2018 - 01/2011
3	Erythropoietin FDA Link 01/2013 - 01/2011
3	cobaltous chloride (cobalt(II)chloride)IBA 08/2011 - 07/2007
3	3-Mercaptopropionic Acid (3 Mercaptopropionic Acid)IBA 03/2009 - 02/2004
2	CannabinoidsIBA 03/2021 - 03/2020
2	Biological ProductsIBA 01/2021 - 04/2019
2	IronIBA 01/2021 - 01/2018
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
2	eculizumab FDA Link 06/2020 - 02/2014
2	Erythropoietin Receptors (Erythropoietin Receptor)IBA 01/2019 - 08/2011
2	Tyrosine Kinase InhibitorsIBA 11/2015 - 09/2015
2	Monoclonal AntibodiesIBA 02/2014 - 02/2004
2	Subfamily B ATP Binding Cassette TransporterIBA 01/2014 - 02/2004
2	Phenytoin (Dilantin)FDA LinkGeneric 01/2013 - 02/2007
1	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 01/2022
1	Ion Channels (Ion Channel)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	HemosiderinIBA 01/2021
1	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 01/2021
1	decan-4-olideIBA 01/2021
1	sebacic acidIBA 01/2021
1	PotassiumIBA 01/2021
1	piperineIBA 10/2020
1	ResveratrolIBA 10/2020
1	alpha-Tocopherol FDA Link 10/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 06/2020
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 06/2020
1	tariquidar (XR9576)IBA 01/2020
1	ElementsIBA 04/2019
1	Rhodamine 123IBA 01/2019
1	Free RadicalsIBA 01/2018
1	Chelating AgentsIBA 01/2018
1	Kainic Acid (Kainate)IBA 01/2017
1	Protein Isoforms (Isoforms)IBA 01/2017
1	ErbB Receptors (EGF Receptor)IBA 11/2015
1	Phosphotransferases (Kinase)IBA 11/2015
1	masitinibIBA 06/2015
1	Metabotropic Glutamate 5 ReceptorIBA 08/2014
1	mavoglurantIBA 08/2014
1	Levodopa (L Dopa)FDA LinkGeneric 08/2014
1	Complement System Proteins (Complement)IBA 02/2014
1	Mitogen-Activated Protein KinasesIBA 07/2013
1	CytokinesIBA 07/2013
1	Messenger RNA (mRNA)IBA 07/2013
1	Growth Factor ReceptorsIBA 01/2013

Therapy/Procedure

5	Therapeutics 01/2021 - 05/2009
4	Drug Therapy (Chemotherapy) 01/2014 - 02/2004
1	Chelation Therapy (Therapy, Chelation) 01/2021
1	Blood Transfusion (Blood Transfusions) 01/2021